Amarin Corporation plc: Amarin Highlights New Data Providing

- New Research Demonstrates Multifactorial Beneficial Effects of VASCEPA/VAZKEPA on Coronary Physiology and Plaque Progression - --Data Further Advances Understanding of VASCEPA/VAZKEPA Potential Mechanism

Related Keywords

Sweden , Finland , Lebanon , Dublin , Ireland , Massachusetts , United States , Loyola University , Illinois , Chicago , Leipsic , Offaly , Boston , Switzerland , New Jersey , Canada , United Arab Emirates , American , Mark Marmur , Coll Cardiol , Markg Rabbat , Mohamad Kassab , Nabil Abadir , Clin Cardiol , Lisa Defrancesco , Farouc Jaffer , Amarin Pharmaceuticals Ireland , Nasdaq , Journal Of The American College Cardiology , American Heart Association , Exchange Commission , European Union , American Heart Association Vascular Discovery , Investor Relations Amarin Corporation , Drug Administration , Corporate Communications , Head Of Global Medical Affairs , Research Demonstrates Multifactorial Beneficial , A Report From The American Heart Association , Amarin Corporation , Coronary Physiology , Plaque Progression , Data Further Advances Understanding , European Heart Journal , Vascular Discovery , Icosapent Ethyl , Coronary Physiology Assessed , Cardiac Computed Tomography , Vivo Atheroma Progression , Inflammatory Protease , Chronic Total Occlusion , Chief Medical Officer , Global Medical Affairs , New England Journal , American College , United Arab , Private Securities Litigation Reform Act , Securities Act , Relations Amarin Corporation , Heartj Cardiovasc , Flow Reserve Derived , Stable Coronary Artery , Year Impact , Medical Practice , Clinical Outcomes , Heart Disease , Report From , American Heart , Cardiovascular Events , Icosapent Ethyl Intervention , Cardiovascular Risk Reduction , Total Ischemic Events , Gefallene Big Techs , Amarin , Corporation , Highlights , Data , Roviding , Potential , Mechanistic , Insight , Vascepa , Vazkepa , Icosapent , Methyl , Reduction , Ardiovascular , Events ,